In addition, immunofluorescence of mouse subcutaneous cancer specimens showed that macrophage marker F4/80 was not significantly different among the groups, while M2 macrophage marker CD206 was upregulated in the two groups injected with IL-4 (Supplementary Fig. 5G, H). This evidence concerns the gene IL4 and cancer.